Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies.
Conclusion: According to these data, monitoring this class of toxicities is of primary importance to avoid hypertension worsening and, thus, the risk of major cardiovascular events.
PMID: 31829045 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cervical Cancer | Clinical Trials | Colorectal Cancer | Heart | Hypertension | Prostate Cancer | Study | Toxicology